Clinical Trial Update: Extended Use of Cannabidiol for the Prevention of Graft-versus-host-disease [Phase 2]

View source ↗

Summary

This is an update on a Phase 2 clinical trial evaluating extended use of cannabidiol to prevent graft-versus-host disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Rabin Medical Center | Conditions: Graft vs Host Disease | Phase 2 | Status: UNKNOWN